Simultaneous paraneoplastic cerebellar degeneration, Lambert-Eaton syndrome and neuropathy associated with AGNA/anti-SOX1 and VGCC antibodies
Abstract Anti-glial nuclear antibody (AGNA) is an onconeuroal antibody targeting the nuclei of Bergmann glia in the cerebellum and Anti-SRY-related HMG-box 1 (SOX1). It is highly specific for small cell lung cancer (SCLC) and correlates to the appearance of paraneoplastic neurological syndromes such...
Main Authors: | Jonas Feldheim, Cornelius Deuschl, Martin Glas, Christoph Kleinschnitz, Tim Hagenacker |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | Neurological Research and Practice |
Online Access: | https://doi.org/10.1186/s42466-021-00129-w |
Similar Items
-
Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
by: Lorenzoni, P, et al.
Published: (2008) -
Utility of cerebellar inhibition in paraneoplastic cerebellar degeneration with Lambert-Eaton myasthenic syndrome (PCD-LEMS): diagnosis and follow-up
by: Takahiro Shimizu, et al.
Published: (2025-01-01) -
Atypical Presentation of Seronegative Paraneoplastic Lambert–Eaton Myasthenic Syndrome with Cerebellar Ataxia
by: Shalesh Rohatgi, et al.
Published: (2024-06-01) -
Lambert-Eaton Myasthenic Syndrome and Paraneoplastic Cerebellar Degeneration Associated with Merkel Cell Carcinoma with Unknown Primary: A Case Report
by: Andrea Agostini, et al.
Published: (2021-05-01) -
Late onset cerebellar ataxia syndrome after non-paraneoplastic Lambert-Eaton myasthenic syndrome: a case study
by: David P. Randall, et al.
Published: (2025-01-01)